Terms: = Colorectal cancer AND VTI1A, ENSG00000151532, Vti1-rp2, MVti1, 143187
8 results:
1. Comprehensive genetic characterization of rectal cancer in a large cohort of Japanese patients: differences according to tumor location.
Hino H; Shiomi A; Hatakeyama K; Kagawa H; Manabe S; Yamaoka Y; Nagashima T; Ohshima K; Urakami K; Akiyama Y; Yamaguchi K
J Gastroenterol; 2022 Jul; 57(7):476-485. PubMed ID: 35449312
[TBL] [Abstract] [Full Text] [Related]
2. Genetic colorectal cancer and Adenoma Risk Variants Are Associated with Increasing Cumulative Adenoma Counts.
Sullivan BA; Qin X; Redding TS; Gellad ZF; Stone A; Weiss D; Madison AN; Sims KJ; Williams CD; Lieberman D; Hauser ER; Provenzale D
Cancer Epidemiol Biomarkers Prev; 2020 Nov; 29(11):2269-2276. PubMed ID: 32928932
[TBL] [Abstract] [Full Text] [Related]
3. The vti1a-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
Davidsen J; Larsen S; Coskun M; Gögenur I; Dahlgaard K; Bennett EP; Troelsen JT
PLoS One; 2018; 13(7):e0200215. PubMed ID: 29975781
[TBL] [Abstract] [Full Text] [Related]
4. Cumulative evidence for relationships between multiple variants in the vti1a and TCF7L2 genes and cancer incidence.
Zhang M; Tang M; Fang Y; Cui H; Chen S; Li J; Xiong H; Lu J; Gu D; Zhang B
Int J Cancer; 2018 Feb; 142(3):498-513. PubMed ID: 28949031
[TBL] [Abstract] [Full Text] [Related]
5. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in vti1a.
Wang H; Burnett T; Kono S; Haiman CA; Iwasaki M; Wilkens LR; Loo LW; Van Den Berg D; Kolonel LN; Henderson BE; Keku TO; Sandler RS; Signorello LB; Blot WJ; Newcomb PA; Pande M; Amos CI; West DW; Bézieau S; Berndt SI; Zanke BW; Hsu L; ; Lindor NM; Haile RW; Hopper JL; Jenkins MA; Gallinger S; Casey G; ; Stenzel SL; Schumacher FR; Peters U; Gruber SB; ; Tsugane S; Stram DO; Le Marchand L
Nat Commun; 2014 Aug; 5():4613. PubMed ID: 25105248
[TBL] [Abstract] [Full Text] [Related]
6. Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer.
Shanmugam V; Ramanathan RK; Lavender NA; Sinari S; Chadha M; Liang WS; Kurdoglu A; Izatt T; Christoforides A; Benson H; Phillips L; Baker A; Murray C; Hostetter G; Von Hoff DD; Craig DW; Carpten JD
BMC Med Genomics; 2014 Jun; 7():36. PubMed ID: 24943349
[TBL] [Abstract] [Full Text] [Related]
7. High frequency of fusion transcripts involving TCF7L2 in colorectal cancer: novel fusion partner and splice variants.
Nome T; Hoff AM; Bakken AC; Rognum TO; Nesbakken A; Skotheim RI
PLoS One; 2014; 9(3):e91264. PubMed ID: 24608966
[TBL] [Abstract] [Full Text] [Related]
8. Genomic sequencing of colorectal adenocarcinomas identifies a recurrent vti1a-TCF7L2 fusion.
Bass AJ; Lawrence MS; Brace LE; Ramos AH; Drier Y; Cibulskis K; Sougnez C; Voet D; Saksena G; Sivachenko A; Jing R; Parkin M; Pugh T; Verhaak RG; Stransky N; Boutin AT; Barretina J; Solit DB; Vakiani E; Shao W; Mishina Y; Warmuth M; Jimenez J; Chiang DY; Signoretti S; Kaelin WG; Spardy N; Hahn WC; Hoshida Y; Ogino S; DePinho RA; Chin L; Garraway LA; Fuchs CS; Baselga J; Tabernero J; Gabriel S; Lander ES; Getz G; Meyerson M
Nat Genet; 2011 Sep; 43(10):964-968. PubMed ID: 21892161
[TBL] [Abstract] [Full Text] [Related]
